Navigation Links
Streptavidin Magnetic Beads

ProductsStreptavidin Magnetic Beads
Company New England Biolabs, Inc.
Item Streptavidin Magnetic Beads
Features Support Matrix: 1 M nonporous superparamagnetic bead
Description Streptavidin magnetic beads are 1 m superparamagnetic beads covalently coupled to a form of streptavidin. Captured substrates can be useful as ligands in subsequent experiments including mRNA isolation and the capture of primary or secondary antibodies.
Info New England Biolabs, Inc.
Customer Service: 978-927-5054
Web site: http://www.neb.com/nebecomm/default.asp?

Related medicine products :

1. Dynabeads® MyOne™ Streptavidin T1
2. QuantumPlex Streptavidin Beads
3. Streptavidin MicroBeads
4. MagnaBind™ Streptavidin Beads
5. BcMag Streptavidin Magnetic Beads
6. Streptavidin A-Beads
7. Biotin-Trapper™ Streptavidin Magnetic Beads
8. Streptavidin functionalized M-PVA Magnetic Beads
9. Hi-Flux™ Streptavidin Magnetic Beads
10. MagaCell™-Streptavidin
11. Bio-Adembeads Magnetic Beads Conjugated To Streptavidin
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products:
(Date:12/14/2009)... 15 In today,s academic medical centers, ... ever. Now the University HealthSystem Consortium (UHC) has ... Analysis: Achieving Cost Efficiencies in Health Care, ... environments. These new materials, developed with the input ... a practical guide to planning, implementing, and managing ...
(Date:12/14/2009)... Ill. and HOLLYWOOD, Fla., Dec. 14 /PRNewswire-FirstCall/ ... announced today a definitive agreement to acquire ... a leading provider of laboratory information management ... ,, The acquisition strengthens Abbott,s competitive ... advanced web-based applications to help laboratories efficiently ...
(Date:12/14/2009)... Aflac Incorporated announced today that it ... senior notes with a coupon of 6.9%. The ... 98.951 to yield 6.984%. The company anticipates using ... and general corporate purposes. ,, Commenting on the ... and Chief Financial Officer Kriss Cloninger III commented: ...
(Date:12/14/2009)... Twelve variants seen in one gene, researchers say , , ... pinpointed a dozen genetic variants in a single gene ... University School of Medicine in St. Louis analyzed the ... heart failure, and identified 129 variants in four genes ... of 1,117 whites with heart failure and 625 healthy ...
(Date:12/14/2009)... doses from common CT procedures vary widely and are higher than ... a new study led by University of California, San Francisco ... ... (Vocus) December 14, 2009 -- Radiation doses from common CT procedures ... increased risk for cancer, according to a new study led by ...
Breaking Medicine News(10 mins):Health News:University HealthSystem Consortium Offers Value Analysis Professionals Insightful New Resources 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 2Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 3Health News:Abbott to Acquire STARLIMS Technologies Ltd., a Leader in Laboratory Information Management Systems 4Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 2Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 3Health News:Aflac Incorporated Prices $400 Million of 30-Year Senior Notes 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 2Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 3Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 4Health News:Variable Doses of Radiation Raise Safety Concerns for CT Procedures 5
... hospitals associated with Fox Chase Cancer Center in ... academic cancer center, where most new treatment protocols ... is provided, is a highly effective model for ... , Fox Chase, an NCI-designated Comprehensive ...
... - Celecoxib, the anti-inflammatory medication also known by the ... reduces a specific proliferation measurement of precancerous lesions in ... of Texas M. D. Anderson Cancer Center. This finding ... cancer in individuals at higher risk of developing the ...
... 15 JumpStart Inc., the Northeast Ohio,venture ... innovative,early-stage businesses and ideas, has announced an ... Cleveland-based company is,commercializing a patented, Federal Drug ... easily measure cervical length in,pregnant women, which ...
... focus of 48 NQF-endorsed measures, WASHINGTON, May ... hurdle in the United States, the National Quality,Forum ... on,measuring the performance of acute care hospitals, including ... care,of venous thromboembolism., "It has been difficult ...
... does not appear to help quality of life for ... (HealthDay News) -- Adding chemotherapy to other treatments being ... linked to asbestos exposure, does not appear to improve ... mesothelioma (MPM), which is usually fatal, is a cancer ...
... AARP commends Governor Paterson,s leadership in proposing prescription,drug ... 15 AARP strongly believes,New York has a ... proposals which address the undue influence that,pharmaceutical companies ... pocket books but the treatment they receive., ...
Other Medicine News:Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 2Health News:Celebrex shows benefit in first-of-its-kind lung cancer chemoprevention trial 3Health News:CerviLenz Receives JumpStart Investment 2Health News:CerviLenz Receives JumpStart Investment 3Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 2Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 3Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 4Health News:National Quality Forum Endorses Consensus Standards for Quality of Hospital Care 5Health News:Chemo for Mesothelioma Offers Limited Survival Benefits 2Health News:AARP Statement on Governor's Bill for Prescription Drug Marketing Reform and Transparency 2
(Date:12/14/2009)... DENVER, Dec. 14 Corgenix Medical ... developer and marketer of diagnostic test kits, ... Massachusetts-based life sciences company, announced today a ... Galectin-3 diagnostic products in enzyme-linked immunosorbent assay ... BG Medicine is seeking regulatory clearance in ...
(Date:12/14/2009)... CHICAGO, Dec. 14 Sword Diagnostics, Inc. ... Patent Office (USPTO) has issued patent number ... Biological Organisms using Raman Scattering" to the company. ... on improved sensitivity. ,, "The issuance of ... move forward with our continued development and commercialization," ...
(Date:12/14/2009)... Southridge LLC ("Southridge"), an investment ... is pleased to announce that its affiliated fund has ... $15 million in equity financing to Imaging Diagnostic Systems, ... of financing the growth of Imaging Diagnostic Systems, Southridge ... new developments in the field of early breast cancer ...
Breaking Medicine Technology:Corgenix and BG Medicine Announce Supply Agreement for BGM Galectin-3(TM) 2Southridge LLC Provides Funding Through Private Equity Agreement with Imaging Diagnostic Systems, Inc. 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 15109 1Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 15109 2Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas 15109 3AIUM gears up for 2010 Annual Convention in San Diego California 62893 1AIUM gears up for 2010 Annual Convention in San Diego California 62893 2Possible ovarian cancer treatment target identified 62890 1Possible ovarian cancer treatment target identified 62890 2